Uncategorized

FDA allows standalone use of nasal spray antidepressant Spravato (esketamine)

todayJanuary 21, 2025 323 49 4

Background
share close

Spravato, the brand name for esketamine, has a newly approved indication for treatment-resistant depression.

The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its own. It was approved in 2019 to treat severe depression.

(Image credit: tadamichi/Getty Images/iStockphoto)

Written by: Prometheus

Rate it

Listen

Our radio is always online!
Listen now completely free!
Email us to ADVERTISE

Based in and Broadcasting from the USA we’re the home of 4 Formats around the clock Weekly … 6am till Noon  will satisfy your cravings for the 80s, while at Noon we uncork the Rock and Metal your inner Metal monster Craves. 

At 6 pm we are all about  the Alternative Rock of the 80s & 90s … Overnight is a special blend just for those of you that keep the Night Pulse of America!

ASCAP License Number 400012286 

Powering the USA’s Web Rock Revolution!